Stephen Langley
Royal Surrey County Hospital, Royal Surrey NHS Foundation Trust
Papers
3
Total Citations
469
H-Index
3
About
Stephen Langley is a leading urologic oncologist whose research centers on the treatment and management of prostate cancer, with a particular focus on optimizing therapeutic outcomes and developing salvage strategies for recurrent disease. His most influential contribution is the landmark 2012 study from the Prostate Cancer Results Study Group, which provided a comprehensive comparative analysis of prostate-specific antigen (PSA) free survival outcomes across low, intermediate, and high-risk prostate cancer patients treated with radical therapy. This work, cited over 450 times, established critical benchmarks for evaluating treatment effectiveness using PSA as the most sensitive measurement tool, directly informing clinical decision-making worldwide. Langley has also pioneered advanced surgical techniques for managing isolated recurrences after primary treatment, including robot-assisted salvage seminal vesicle excision following low-dose-rate brachytherapy. His innovative work on salvage vesiculectomy, detailed in recent publications, demonstrates his commitment to developing minimally invasive approaches that preserve functional outcomes while effectively addressing local cancer recurrence. Through these contributions, Langley has significantly advanced the field of prostate cancer treatment, providing evidence-based frameworks for risk-stratified therapy and expanding surgical options for patients with recurrent disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3